October 20, 2016
Ionis Pharmaceuticals has retained The Chase Group, Inc. to continue to help build their Drug Safety team. This new recruitment will be for an Executive Director MD.
Ionis is the leading company in RNA-targeted drug discovery and development focused on developing drugs for patients who have the highest unmet medical needs, such as those patients with severe and rare diseases. Using its proprietary antisense technology, Ionis has created a large pipeline of first-in-class or best-in-class drugs, with over a dozen drugs in mid- to late-stage development.
If you would like further details, please contact Ken Allison at: ken@chasegroup.com
